József Mandl

Title: József Mandl: Innovator in Hepatology and Obesity Treatment

Introduction

József Mandl is a notable inventor based in Budapest, Hungary. He has made significant contributions to the fields of hepatology and obesity treatment through his innovative research and patented methods. With a total of 2 patents, Mandl continues to push the boundaries of medical science.

Latest Patents

Mandl's latest patents focus on critical health issues. One patent details methods for treating non-alcoholic steatohepatitis (NASH) and preventing NASH-induced hepatocellular carcinoma (HCC). This patent discloses methods that include administering O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime (BGP15), either alone or in combination with an inhibitor of the interleukin-6 receptor transsignaling response, particularly gp130Fc. Another patent addresses the prevention and treatment of obesity, utilizing BGP-15 or a pharmaceutically suitable acid addition salt thereof to prevent or reduce weight gain.

Career Highlights

József Mandl is affiliated with N-gene Research Laboratories, Inc., where he applies his expertise to develop innovative solutions for pressing health challenges. His work has garnered attention in the scientific community, contributing to advancements in treatment methodologies.

Collaborations

Mandl has collaborated with esteemed colleagues, including Mark Anthony Febbraio and Péter Literáti Nagy. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

József Mandl stands out as a pioneering inventor in the medical field, particularly in the treatment of NASH and obesity. His contributions through patented methods reflect his commitment to improving health outcomes.